The Animal Drug Compounding Market report by Persistence Market Research goes by the changing trend of consumerism all across the healthcare vertical. “Going cashless” is amongst the “new” normals. Inorganic growth has also picked up. Key participants of the healthcare value chain – both – private and public – have joined hands for competing in the ever-demanding landscape.
Global demand for animal drug compounding is expected to significantly increase, owing to the unavailability of FDA-approved animal drugs. Compounded prescriptions for animal species are considered to be significantly higher than those for branded prescription drugs.
For instance, in 2017, the U.S. FDA estimated that, 75,000 pharmacies in the U.S. fill 6,350,000 animal compounding prescriptions.
Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12871
Company Profiles
- Hoye’s Pharmacy
- Vertisis Custom Pharmacy
- Smith Caldwell Drug Store
- Sixth Avenue Medical Pharmacy
- Dougherty’s Pharmacy
- Triangle Compounding Pharmacy Inc.
- Medisca Inc.
- Wedgewood Pharmacy
- Millers Pharmacy
- Chiron Compounding Pharmacy
- MEDS Canadian Compounding Pharmacy
- Aurora Compounding
- Pace Pharmacy
- Victoria Compounding Pharmacy
- Pratt’s Compounding Pharmacy
- People’s Choice Pharmacy
Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12871
Persistence Market Research predicts that, the global animal drug compounding market would be valued at US$ 1.5 Bn in 2019, and will expand at an 8% CAGR over the forecast period (2019-2029).
Key Takeaways of Animal Drug Compounding Market Study
- Hormonal drugs, manipulating the emotions and moods of pets, are expected to gain traction during the forecast period.
- Increasing adoption of companion animals is expected to contribute to significant dominance of the segment during the forecast period.
- Orally formulation of drugs is expected to hold more than80% of the global animal drug compounding market share by the end of 2029.
- In terms of formulation, the injectable segment is expected to grow 6Xby the end of 2029.
- Leading medical & pharmaceutical companies are collaborating with small compounding solution providers, hospitals, and research facilities to strengthen their market position.
- North America is expected to dominate the global animal drug compounding market, owing to increasing adoption of compounded medication with alternate dosage forms and added flavors.
“Unavailability of generic medications for animals in desired dosage forms is pushing the production of compounded drugs, thus driving the growth of the animal drug compounding market during the forecast period”, says a PMR analyst.
Access Full Report @ https://www.persistencemarketresearch.com/checkout/12871
CNS Drugs Dominating Animal Drug Compounding Market
Central nervous system inflammation is the most common cause of neurological disorders in dogs and cats. Abnormal limb coordination, seizures, behavioural changes, and blindness are cited as the most common abnormalities in dogs and cats with central nervous system inflammation.
For instance, according to the International Journal of Pharmaceutical Compounding, central nervous system drugs were the most commonly dispensed medications from animal drug compounding pharmacies with approximately 39% of the total veterinary prescriptions.
What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the animal drug compounding market in its latest study, presenting historical demand assessment from 2014-2018 and projections from 2019-2029, on the basis of product type (CNS agents, anti-infective agents, hormones and substitutes, anti-inflammatory agents, others), animal type (companion animals and livestock), formulation (oral, injectable, and others), across seven key regions.
Explore Extensive Coverage of Persistence Market Research’s Healthcare Industry
Related Reports:
Surgical And Respiratory Masks Market:
The global surgical and respiratory masks market is expected to expand at an impressive CAGR of 8% during the forecast period of 2020 to 2030, to be valued around US$ 6.7 Bn by 2030.
Ankle Syndesmosis Treatment Devices Market:
Recent technological advancements and adoption of new implant materials for various indications, fractures, and support injuries have transformed the ankle syndesmosis treatment devices market.
Biobetters Market:
According to the latest research by the company, the global biobetters market is projected to account for a market value of around US$ 99,000.0 Mn by the end of 2029.
About us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com